I kliniske undersøgelser med 73 tidligere behandlede patienter (TBP, defineret som udsat for mere end 100 eksponeringsdage), fulgt over fire år, observerede man ingen de- novo inhibitorer.
In clinical studies with 73 previously treated patients (PTP, defined as having more than 100 exposure days), followed over four years, no de-novo inhibitors were observed.